Skip to main content

Manuel Quintana Luque

I am a biostatistician with a PhD in medicine. Since 2001, I have been working in research groups affiliated with the Neurology Department, and currently, I am a part of the Epilepsy Unit at HUVH and the Research Group on Status Epilepticus and Acute Seizures. at VHIR. My main activity consists of managing epilepsy projects and clinical trials, as well as conducting data analysis for different ongoing projects within the group

Institutions of which they are part

Research technician
Research Group on Status Epilepticus and Acute Seizures
Vall Hebron Institut de Recerca
Neurology
General Hospital

Manuel Quintana Luque

Institutions of which they are part

Research technician
Research Group on Status Epilepticus and Acute Seizures
Vall Hebron Institut de Recerca
Neurology
General Hospital

I am a biostatistician with a PhD in medicine. Since 2001, I have been working in research groups affiliated with the Neurology Department, and currently, I am a part of the Epilepsy Unit at HUVH and the Research Group on Status Epilepticus and Acute Seizures. at VHIR. My main activity consists of managing epilepsy projects and clinical trials, as well as conducting data analysis for different ongoing projects within the group

Diploma in Statistics (2000) and Bachelor's degree in Applied Statistics (2011) from UAB. I completed the Master's degree in Bioinformatics and Biostatistics at UOC (2019), and more recently, I obtained my PhD in medicine from UAB (2022) with an epidemiological and hospital cost study of epilepsy.
With over 20 years of experience as a biostatistician in the Neurology Department, I have conducted statistical analysis of data from national competitive projects as well as internal research projects. Currently, I am part of the research team in epilepsy, where I am actively involved in research activities, managing various projects and trials within the group, as well as handling statistical and bioinformatic data.
I am the co-author of over 150 articles published in indexed journals, mostly derived from projects related to epilepsy. Currently, I am a co-investigator on two competitive projects within the group, primarily focused on the search for biomarkers (proteins and microRNA) associated with epileptic status and the prediction of new epileptic seizures.

Projects

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50600
Reference: 2005SGR 00614
Duration: 01/01/2006 - 31/12/2008

Monitorización continua de la glucemia en el ictus tratado con tPA. Relación entre la glucemia en el momento de la reperfusión y el pronóstico.

IP: José Alvarez Sabin
Collaborators: Marc Ribó Jacobi, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 72450
Reference: PI030139
Duration: 01/01/2004 - 28/11/2006

Influencia de las metaloproteasas de matriz en las complicaciones hemorrágicas tras el tratamiento trombolítico en el ictus isquémico.

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Marc Ribó Jacobi, Carlos Molina Cateriano, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 33005
Reference: PI020773
Duration: 06/11/2002 - 06/11/2005

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana  Leon  Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.